Fourth, considering that preclinical studies have also shown pro-cathepsin D overexpression in breast cancer and hepatocellular carcinoma [10, 12, 17, 18], it was postulated that pleural pro-cathepsin D may serve as a potential biomarker for diagnosing MPE. The gene discussed is CTSD; the disease is hepatocellular carcinoma.